Table 2.
Number of DDD per 100,000 inhabitants per day (DID100,000) attributed to dental prescriptions in England, Scotland, Norway and Sweden
| Year | Antibiotics | England | Scotland | Norway | Sweden |
|---|---|---|---|---|---|
| DID100,000 | |||||
| 2010 | (Amxy) – (Phxy) – (Met) | No data | (70.28)–(2.02) − (10.40) | (7.57)–(68.49) – (3.52) | (10.28)–(80.37) – (3.29) |
| (Clin) – (Ery) – (Doxy) | No data | (0.38)–(4.62) − (1.32) | (4.03)–(2.94) –(1.84) | (4.15)–(0.54) – (1.36) | |
| (Tet) – (Oxy) – (Azy) | No data | (0.12)–(0.05) − (0) | (0.56)–(0.12) – (1.06) | (0.08)–(0) – (0.02) | |
| (Coamxy) – (Spir) | No data | (0.26)–(0) | (0)–(0.17) | (0)–(0) | |
| 2011 | (Amxy) – (Phxy) – (Met) | (89.93)–(0.94) – (13.66) | (76.39)–(1.99) – (11.35) | (7.82)–(67.70) – (3.55) | (10.26)–(80.49) – (3.26) |
| (Clin) – (Ery) – (Doxy) | (0.45)–(6.16) – (0.52) | (0.34)–(4.67) − (1.43) | (4.21)–(2.84) – (1.83) | (4.37)–(0.49) – (1.46) | |
| (Tet) – (Oxy) – (Azy) | (0.16)–(0.06) – (0.01) | (0.14)–(0.05) − (0) | (0.43)–(0.06) – (1.20) | (0.09)–(0) – (0.02) | |
| (Coamxy) – (Spir) | (0.34)–(0) | (0.28)–(0) | (0)–(0.15) | (0)–(0) | |
| 2012 | (Amxy) – (Phxy) – (Met) | (89.45)–(0.76) – (13.56) | (79.66)–(1.78) – (11.96) | (8.27)–(66.06) – (3.66) | (10.16)–(78.05) – (3.27) |
| (Clin) – (Ery) – (Doxy) | (0.42)–(6.03) – (0.49) | (0.33)–(4.64) – (1.54) | (4.56)–(2.61) – (2.0) | (4.21)–(0.40) – (1.51) | |
| (Tet) – (Oxy) – (Azy) | (0.13)–(0.05) –(0.04) | (0.13)–(0.05) – (0.02) | (0.37)–(0) – (1.19) | (0.10)–(0) – (0.02) | |
| (Coamxy) – (Spir) | (0.42)–(0) | (0.20)–(0) | (0)–(0.15) | (0) – (0) | |
| 2013 | (Amxy) – (Phxy) – (Met) | (87.14)–(0.62) – (13.21) | (78.38)–(1.48) – (11.68) | (8.88)–(65.37) – (3.78) | (8.58)–(74.74) – (3.02) |
| (Clin) – (Ery) – (Doxy) | (0.36)–(5.73) – (0.45) | (0.29)–(4.29) – (1.24) | (4.79)–(2.53) – (1.82) | (3.73)–(0.31) – (1.27) | |
| (Tet) – (Oxy) – (Azy) | (0.11)–(0.04) – (0.05) | (0.14)–(0.04) – (0.03) | (0.34)–(0) – (1.18) | (0.07)–(0) – (0.03) | |
| (Coamxy) – (Spir) | (0.43)–(0) | (0.25)–(0) | (0)–(0.13) | (0) – (0) | |
| 2014 | (Amxy) – (Phxy) – (Met) | (87.19)–(0.48) – (13.08) | (85.35)–(1.23) – (11.03) | (9.45)–(65.05) – (3.80) | (7.43)–(69.76) – (2.68) |
| (Clin) – (Ery) – (Doxy) | (0.33)–(5.35) – (0.38) | (0.24)–(3.84) – (1.09) | (5.21)–(2.31) – (1.86) | (3.21)–(0.25) – (1.04) | |
| (Tet) – (Oxy) – (Azy) | (0.09)–(0.04) – (0.06) | (0–09) – (0.02) – (0.02) | (0.34)–(0) – (1.09) | (0.06)–(0) – (0.03) | |
| (Coamxy) – (Spir) | (0.46)–(0) | (0.20)–(0) | (0)–(0.14) | (0) – (0) | |
| 2015 | (Amxy) – (Phxy) – (Met) | (85.04)–(0.37) – (12.46) | (85.90)–(0.92) – (9.92) | (9.39)–(63.66) – (3.52) | (7.37)–(68.33) – (2.51) |
| (Clin) – (Ery) – (Doxy) | (0.30)–(4.85) – (0.35) | (0.18)–(3.37) – (1.02) | (5.27)–(1.98) – (1.81) | (3.18)–(0.24) – (0.96) | |
| (Tet) – (Oxy) – (Azy) | (0.07)–(0.03) – (0.06) | (0.06)–(0.03) – (0.02) | (0.28)–(0) – (0.95) | (0.05)–(0) – (0.03) | |
| (Coamxy) – (Spir) | (0.44)–(0) | (0.16)–(0) | (0)–(0.13) | (0) – (0) | |
| 2016 | (Amxy) – (Phxy) – (Met) | (80.93)–(0.29) – (11.77) | (82.92)–(0.68) – (9.56) | (9.52)–(58.65) – (3.39) | (6.99)–(66.86) – (2.52) |
| (Clin) – (Ery) – (Doxy) | (0.28)–(4.47) – (0.32) | (0.19)–(2.52) – (0.86) | (4.58)–(1.81) – (1.37) | (3.02)–(0.21) – (0.88) | |
| (Tet) – (Oxy) – (Azy) | (0.05)–(0.03) – (0.06) | (0.05)–(0.03) – (0.01) | (0.27)–(0) – (0.82) | (0.04)–(0) – (0.04) | |
| (Coamxy) – (Spir) | (0.40)–(0) | (0.13)–(0) | (0)–(0.11) | (0) – (0) | |
Amxy Amoxicillin, Phxy Phenoxymethyl penicillin, Met Metronidazole, Clin Clindamycin, Ery Erythromycin, Doxy Doxycycline, Tet Tetracycline, Oxy Oxytetracycline, Azy Azithromycin, Coamxy Co-amoxiclav